Temefos

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Temefos
DrugBank Accession Number
DB12231
Background

Diphos has been used in trials studying the treatment of Plasmodium Falciparum Malaria.

Type
Small Molecule
Groups
Investigational
Structure
Thumb
Weight
Average: 466.46
Monoisotopic: 465.989725882
Chemical Formula
C16H20O6P2S3
Synonyms
  • Diphos
  • Temefos
External IDs
  • AC-52160
  • EI-52160
  • ENT-27165

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcrivastineThe risk or severity of QTc prolongation can be increased when Acrivastine is combined with Temefos.
AdenosineThe risk or severity of QTc prolongation can be increased when Temefos is combined with Adenosine.
AjmalineThe risk or severity of QTc prolongation can be increased when Ajmaline is combined with Temefos.
AlfuzosinThe risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Temefos.
AlimemazineThe risk or severity of QTc prolongation can be increased when Alimemazine is combined with Temefos.
AmantadineThe risk or severity of QTc prolongation can be increased when Amantadine is combined with Temefos.
AmifampridineThe risk or severity of QTc prolongation can be increased when Temefos is combined with Amifampridine.
AmiodaroneThe risk or severity of QTc prolongation can be increased when Temefos is combined with Amiodarone.
AmisulprideThe risk or severity of QTc prolongation can be increased when Amisulpride is combined with Temefos.
AmitriptylineThe risk or severity of QTc prolongation can be increased when Temefos is combined with Amitriptyline.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenyl thiophosphates. These are organothiophosphorus compounds that contain a thiophosphoric acid O-esterified with a phenyl group.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Organic thiophosphoric acids and derivatives
Sub Class
Thiophosphoric acid esters
Direct Parent
Phenyl thiophosphates
Alternative Parents
Diarylthioethers / Thiophosphate triesters / Thiophenol ethers / Phenoxy compounds / Sulfenyl compounds / Organooxygen compounds / Hydrocarbon derivatives
Substituents
Aromatic homomonocyclic compound / Aryl thioether / Benzenoid / Diarylthioether / Hydrocarbon derivative / Monocyclic benzene moiety / Organic oxygen compound / Organooxygen compound / Organosulfur compound / Phenoxy compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
organic thiophosphate, organothiophosphate insecticide (CHEBI:38954) / Organophosphorus insecticides (C18809)
Affected organisms
Not Available

Chemical Identifiers

UNII
ONP3ME32DL
CAS number
3383-96-8
InChI Key
WWJZWCUNLNYYAU-UHFFFAOYSA-N
InChI
InChI=1S/C16H20O6P2S3/c1-17-23(25,18-2)21-13-5-9-15(10-6-13)27-16-11-7-14(8-12-16)22-24(26,19-3)20-4/h5-12H,1-4H3
IUPAC Name
O-4-[(4-{[dimethoxy(sulfanylidene)-λ⁵-phosphanyl]oxy}phenyl)sulfanyl]phenyl O,O-dimethyl phosphorothioate
SMILES
COP(=S)(OC)OC1=CC=C(SC2=CC=C(OP(=S)(OC)OC)C=C2)C=C1

References

General References
Not Available
KEGG Compound
C18809
PubChem Compound
5392
PubChem Substance
347828510
ChemSpider
5199
ChEBI
38954
ChEMBL
CHEMBL1355821
ZINC
ZINC000002027006
Wikipedia
Temefos

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2RecruitingTreatmentPlasmodium Falciparum Malaria (Drug Resistant)1
1CompletedTreatmentPlasmodium Falciparum, Malaria1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.000145 mg/mLALOGPS
logP5.47ALOGPS
logP5.54ChemAxon
logS-6.5ALOGPS
Physiological Charge0ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area55.38 Å2ChemAxon
Rotatable Bond Count10ChemAxon
Refractivity118.36 m3·mol-1ChemAxon
Polarizability43.8 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
MS/MS Spectrum - , positiveLC-MS/MSsplash10-00dl-3954100000-7f419ca88639b07ab15f

Drug created on October 20, 2016 21:41 / Updated on February 21, 2021 18:53